Let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1233-1241

  Zhao, Yingchun ^a   Deng, Caishu ^a   Lu, Weida ^a   Xiao, Jing ^a   Ma, Danjun ^a   Guo, Mingxi ^a   Recker, Robert R ^a   Gatalica, Zoran ^a   Wang, Zhaoyi ^a   Xiao, Gary Guishan ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA 36; MICRORNA; MICRORNA LET 7; MICRORNA LET 7B; MICRORNA LET 7I; TAMOXIFEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; ENZYME INHIBITION; GENE ACTIVITY; GENE INSERTION; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LET 7B GENE; LET 7I GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; REPORTER GENE; SIGNAL TRANSDUCTION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENOME, HUMAN; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TAMOXIFEN; TRANSFECTION;

EID: 82855177909     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00225     Document Type: Article

References (36)

1. Clemons M, Goss P. (2001) Estrogen and the risk of breast cancer. N. Engl. J. Med. 344:276-85.
2. Weihua Z, et al. (2003) Update on estrogen signaling. FEBS Lett. 546:17-24.
3. Evans RM. (1988) The steroid and thyroid hormone receptor superfamily. Science. 240:889-95.
4. Berry M, Metzger D, Chambon P. (1990) Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9:2811-8.
5. Flouriot G, et al. (2000) Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J. 19:4688-700.
6. Li L, Haynes MP, Bender JR. (2003) Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 100:4807-12.
7. Wang Z, et al. (2005) Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem. Biophys. Res. Commun. 336:1023-7.
8. Wang Z, et al. (2006) A variant of estrogen receptor- {alpha}, hER-{alpha}36: transduction of estrogenand antiestrogen-dependent membrane-initiated mitogenic signaling. Proc. Natl. Acad. Sci. U. S. A. 103:9063-8.
9. Segars JH, Driggers PH. (2002) Estrogen action and cytoplasmic signaling cascades. Part I: membrane-associated signaling complexes. Trends Endocrinol. Metab. 13:349-54.
10. Lee LM, et al. (2008) ER-alpha36, a novel variant of ER-alpha, is expressed in ER-positive and -negative human breast carcinomas. Anticancer Res. 28:479-83.
11. Zhang XT, et al. (2010) A positive feedback loop of ER-alpha36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene. 30:770-80.
12. Shi L, et al. (2009) Expression of ER-{alpha}36, a novel variant of estrogen receptor {alpha}, and resistance to tamoxifen treatment in breast cancer. J. Clin. Oncol. 27:3423-9.
13. Calin GA, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 101:2999-3004.
14. Johnson SM, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell. 120:635-47.
15. Lee YS, Dutta A. (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes. Dev. 21:1025-30.
16. Mayr C, Hemann MT, Bartel DP. (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 315:1576-9.
17. Kim HH, et al. (2009) HuR recruits let-7/RISC to repress c-Myc expression. Genes. Dev. 23:1743-8.
18. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1:882-91.
19. Takamizawa J, et al. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64:3753-6.
20. Dahiya N, et al. (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS. One. 3:e2436.
21. Yu F, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 131:1109-23.
22. Wang L, et al. (2010) The Wilms' tumor suppressor WT1 regulates expression of members of the epidermal growth factor receptor (EGFR) and estrogen receptor in acquired tamoxifen resistance. Anticancer Res. 30:3637-42.
23. Hu G, et al. (2009) MicroRNA-98 and let-7 confer cholangiocyte expression of cytokine-inducible Src homology 2-containing protein in response to microbial challenge. J. Immunol. 183:1617-24.
24. Zhao Y, et al. (2010) Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res. Treat. 127:69-80.
25. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. (2007) The role of site accessibility in microRNA target recognition. Nat. Genet. 39:1278-84.
26. Guo H, Ingolia NT, Weissman JS, Bartel DP. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466:835-40.
27. Zou Y, Ding L, Coleman M, Wang Z. (2009) Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36. FEBS Lett. 583:1368-74.
28. Roush S, Slack FJ. (2008) The let-7 family of microRNAs. Trends Cell Biol. 18:505-16.
29. Jerome T, Laurie P, Louis B, Pierre C. (2007) Enjoy the silence: The story of let-7 microRNA and cancer. Curr. Genomics. 8:229-33.
30. Heo I, et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor microRNA. Mol. Cell 32:276-84.
31. Heo I, et al. (2009) TUT4 in concert with Lin28 suppresses microRNA biogenesis through premicroRNA uridylation. Cell. 138:696-708.
32. Kumar MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U. S. A. 105:3903-8.
33. Barh D, Parida S, Parida BP, Viswanathan G. (2008) Let-7, miR-125, miR-205, and miR-296 are prospective therapeutic agents in breast cancer molecular medicine. Gene Ther. Mol. Biolo. 12:189-206.
34. Kang L, et al. (2010) Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol. Endocrinol. 24:709-21.
35. Baek D, et al. (2008) The impact of microRNAs on protein output. Nature. 455:64-71.
36. Selbach M, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature. 455:58-63.